我們期待,成為全球醫藥保健的領航者
我們期待,成為全球醫藥保健的領航者

目前國鼎正針對癌症、自體免疫、神經退化、新陳代謝疾病與孤兒藥品等領域進行新藥研發,致力於在生命的每一階段增進人類的健康與福祉。

保健食品
保健食品

國鼎生技歷經多年努力,利用專屬發酵方法培育珍貴國鼎的牛樟芝,並萃取菌絲體純化出稀有成分 「Antroquinonol®(安卓奎諾爾®) 」

投資人專區
投資人專區

國鼎重視投資人與股東之意見,設有投資人關係聯絡窗口,並定期舉辦法人說明會及股東會,加強資訊揭露的即時性與透明度,保障投資人和股東的權益。

News
Golden Biotechnology Corp. Starts Phase 2 Trial for Efficacy of Antroquinonol in AML after Russian MOH Approval
Read More "News"
R&D Pipeline
We believe, expect and pioneer… “ Based on our ultimate spirit, GBC develops new drug candidates through our solid footstone and promotes health by promising...
Read More "R&D Pipeline"
PHARMACEUTICAL
Antroquinonol® is the pure compound extracted from Antrodia camphorata. Antroquinonol® is patented by Golden Biotech and helps support the immune system.
Read More "PHARMACEUTICAL"

Golden Biotechnology Corporation (GBC), founded by Mr. Sheng Yung, Liu in 2002, is an leading and innovative drug discovery and evidence-based healthy food supplement manufacturing company dedicated to enhancing lives by developing high quality products that prevent and treat diseases.

GBC’s main focus is on new drug R&D, IP right, pharmacology, toxicology and clinical studies. GBC also has successfully built up the screening platforms to identify bioactive compounds from traditional Chinese herbal medicine that includes more than 480 kinds of local plants, 1300 species of fungi, mushrooms and seaweeds.

Throughout 2002-2005, around 400 drug candidates were obtained from these screening platforms. Based on our own core chemical database, the ubiquinone-like structure of Antroquinonol® was actually discovered in 2006 during drug development. The pharmacology and toxicology of Antroquinonol® have been established along with the CMC (Chemistry, Manufacturing, and Controls) development and large-scale cGMP manufacturing of Antroquinonol®.